Organic reactions in live cells – a new fluorogenic click reaction for selective cell-labeling
18 January 2017
Fluorescent probes are an indispensable tool in biological research. They enable the study of biological processes and the specific biomolecules involved in them. Particularly important are probes that become fluorescent only when they react with the biological target of interest. However, the development of such tools is difficult, and complex chemical synthesis is often needed for their preparation. Dr. Milan Vrábel and his team from the Institute of Organic Chemistry and Biochemistry in Prague (IOCB Prague) have now developed a novel chemical reaction which significantly simplifies the whole process. One example of this powerful methodology allows for imaging the place of action of anti-cancer drugs in live cancer cells almost in real time.
Existing methods for the synthesis of fluorogenic compounds require complex structures, so-called fluorophores, which are often prepared using inefficient, multistep synthetic methods. Milan Vrábel and his group at IOCB Prague have now developed a new fluorogenic click reaction which enables the selective labeling of cell structures and biologically active substances directly in live cancer cells. In comparison to existing techniques, the new method uses relatively simple starting compounds. In addition, small molecular tuning of the starting compounds results in complete color control of the reaction products in an expedient manner.
Another substantial advantage is that the colored products are formed directly upon the reaction of the starting compounds. This leads to a significant reduction in undesired background signals, which is a frequent problem when using classical fluorescent probes.
The power of this methodology is exemplified in the selective labeling of different cellular organelles, such as mitochondria, which play an essential role in many biochemical processes. Another important application of the described chemistry is the visualization of therapeutics at their place of action which can be done nearly in real time due to the fast reaction rate. This could be applied to the development of better-targeted drugs which are active only at the place where they are needed, thus reducing side effects and enhancing their therapeutic effect.
The scientists from IOCB Prague have published their findings in the scientific journal Angewandte Chemie.